MIR6772

Across TCGA pan-cancer cohorts, MIR6772 RNA is linked to patient survival in 23 of 34 cancer types, making it the most broadly survival-associated MIR6772 data layer.

The strongest signal is observed in cervical squamous cell carcinoma and endocervical adenocarcinoma (CESC), where higher MIR6772 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated MIR6772 expression acts as an unfavorable survival marker, although some lineages such as ESCA and PAAD show a favorable association.

CESC, CHOL, and ACC are the cancer types where MIR6772 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
CESC	DFS	Quartile	All	0.594	0.820	<.001	92	view →
CHOL	DFS	Median	II,III,IV	0.138	0.572	.003	61	view →
ACC	DFS	Tertile	All	0.447	0.875	<.001	52	view →
ESCA	DFS	Quartile	III,IV	0.594	0.267	.005	24	view →
LGG	DFS	Tertile	All	0.569	0.779	<.001	23	view →
PAAD	OS	Tertile	All	0.540	0.299	.006	20	view →
UVM	OS	Tertile	III,IV	0.224	1.000	.013	17	view →
THYM	DFS	Median	II,III,IV	1.000	0.599	.015	15	view →
LAML	DFS	Median	All	0.257	0.502	.040	14	view →
SKCM	DFS	Tertile	III,IV	0.608	0.375	.006	12	view →
UCEC	OS	Quartile	All	0.462	0.727	.019	12	view →
PRAD	DFS	Quartile	All	0.824	0.907	.010	12	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 23 lineages.

MIR6772–CESC (DFS)

Open the CESC breakdown →